Sarana Meditama Metropolitan Tbk

Overview

SAME Overview

PT Sarana Meditama Metropolitan Tbk is an Indonesia-based company primarily engaged in providing healthcare service by building and operating hospitals. The Company hospitals are operated under the brand name of EMC Healthcare. The Company's specialty centers include cardiovascular center; digestive and bariatric center, and fertility and laparoscopy center. EMC Healthcare consists of seven hospitals that provide health services, namely EMC Alam Sutera Hospital, EMC Cibitung Hospital, EMC Cikarang Hospital, EMC Pekayon Hospital, EMC Pulomas Hospital, EMC Tangerang Hospital, and EMC Sentul Hospital. The Company also operates Grha Kedoya Hospital and Grha MM2100 Hospital through subsidiary PT Kedoya Adyaraya Tbk. The Company's subsidiaries include PT Sarana Meditama International, PT Sarana Meditama Anugerah, PT Sarana Meditama Nusantara, PT Kurnia Sejahtera Utama, PT Elang Medika Corpora, PT Sentosa Indah Sejahtera, and PT Kedoya Adyaraya Tbk.

51015ValueCompetitiveFutureFinancialsDividend
Exchange
Indonesia Stock Exchange

Symbol: SAME

Main
Market Cap.
IDR 4.39Trillion

~$269.54M USD

Industry
Healthcare Providers
Sub-Industry
Healthcare Providers
Sector
Healthcare

Valuation

SAME Valuation Metrics

256

IDR
+1.6%

Closing Price on 2024-07-19

Price to Equity

367.78

P/E

At 367.78x P/E TTM, SAME.JK is trading at a premium to its peers in the Healthcare Equipment & Providers sector (avg 22.0x).

Price to Book

1.21

P/B

At 1.21x P/B TTM, SAME.JK is trading at a discount to its peers in the Healthcare Equipment & Providers sector.

Price to Sales

2.73

P/S

At 2.73x P/S TTM, SAME.JK is trading in line with its peers in the Healthcare Equipment & Providers sector.

Valuing Sarana Meditama Metropolitan Tbk based on its trailing twelve months (TTM) valuation metrics against its peers in the Healthcare Equipment & Providers sector

Historical Price to Earnings

Other Valuation Metrics

Valuing Sarana Meditama Metropolitan Tbk relative to other stocks in the Healthcare Equipment & Providers sector

Price/Cash Flow22.59x
Price/Forward Earnings-
Enterprise Value/Revenue3.22x
Enterprise Value/EBITDA25.72x
PEG Ratio-20.28x

Intrinsic Value

Last closing: IDR2562024-07-19
IDR 5.21

Considerably Lower Intrinsic Value: Analyst's intrinsic value is of SAME is IDR5, which is 97% lower than SAME's last closing price of IDR256 (as of 2024-07-19).

Valuation Recap of SAME stock
WeightNotesScore
High
The P/E ratio is calculated by dividing the market price of a company's stock by its earnings per share (EPS). It is a key tool for investors and analysts to assess whether a stock is overvalued, undervalued, or fairly valued. A P/E ratio of 367.78x is above the ID market average of 8.44x and is trading at a premium to peers in the Healthcare Equipment & Providers sector (22.00x). In fact, less than 25% of its peers trade at a higher P/E ratio than SAME.

High
The P/B ratio is calculated by dividing the market price of a company's stock by its book value per share (BVPS). It measures the company's stock value relative to its assets minus liabilities. A P/B ratio of 1.21x is similar to the peers average of 1.54x in the Healthcare Equipment & Providers sector.

Medium
The P/S ratio is calculated by dividing the market price of a company's stock by its sales per share. It measures the company's stock value relative to its sales. A P/S ratio of 2.73x is similar to the peers average of 2.65x in the Healthcare Equipment & Providers sector. When considered alongside the Forward Price/Earnings ratio, they serve to illustrate investors' expectations of SAME's valuation relative to its current sales and future earnings growth.

Low
The Price/Cash Flow ratio (P/CF) is calculated by dividing the market price of a company's stock by its cash flow per share. It measures the company's stock value relative to its cash flow, and is sometimes said to be a more objective measure of a company's value because cash flows cannot be manipulated as easily as earnings, which considers non-cash items such as depreciation and amortization. SAME's P/CF ratio of 22.59x is considered a relatively high ratio by analysts.

Low
The Enterprise Value/Revenue ratio (EV/R) is calculated by dividing the enterprise value of a company by its revenue. It measures the company's enterprise value relative to its revenue. It is an indicator of how much it costs to buy the company's revenue; the lower the ratio, the cheaper the company's revenue. SAME's EV/R ratio of 3.22x is considered a relatively high ratio. The average EV/R ratio for the Healthcare Equipment & Providers sector is 3.06x.

Medium
Considerably Lower Intrinsic Value: Analyst's intrinsic value is of SAME is IDR 5.21, which is 97% lower than SAME's last closing price of IDR 256.00.

Peers

SAME Peers and Comparison

Peer Companies

Supertype Fuzzy Search
SymbolCompany Name
Market Cap
(in Trillion IDR)
Total Assets
(in Trillion IDR)
Total Revenue
(in Trillion IDR)
Profit and Loss
(in Trillion IDR)
P/E
P/B
KLBFKalbe Farma Tbk72.62T28.96T 30.94T 2.87T 25.323.24
MIKAPT Mitra Keluarga Karyasehat Tbk.41.17T7.81T 4.48T 0.97T 42.256.74
SILOPT Siloam International Hospitals Tbk.34.40T11.42T 11.56T 0.98T 35.274.35
SRAJSejahteraraya Anugrahjaya Tbk27.60T5.62T 2.71T -0.02T -1387.8514.83
SIDOPT Industri Jamu Dan Farmasi Sido Muncul Tbk22.35T4.25T 3.71T 1.04T 21.475.89
HEALPT Medikaloka Hermina Tbk.19.88T9.20T 6.14T 0.52T 38.274.77
TSPCTempo Scan Pacific Tbk9.02T11.93T 13.33T 1.02T 8.881.11
PRAYPT Famon Awal Bros Sedaya Tbk8.52T4.81T 1.93T 0.21T 41.372.96
SOHOPT Soho Global Health Tbk8.50T5.13T 8.58T 0.44T 19.303.37
OMEDPT Jayamas Medica Industri Tbk5.14T2.65T 1.77T 0.27T 19.302.25
Competitiveness Recap of SAME stock
WeightNotesScore
High
At a market cap of IDR 4,389.66 billion, SAME.JK ranks 10 in Market Cap out of 10 companies in the Healthcare sector.

High
At a PE of 367.78, SAME.JK ranks 1 out of 10 companies in the Healthcare sector for P/E value. The average PE is -78.79 (unadjusted). A high P/E ratio often indicates higher growth expectation, or other qualitative factors that led investors to believe that the company has a defensible competitive advantage compared to its peers in Healthcare. false

Medium
At a PE of 367.78, SAME.JK is trading at a higher PE than that of its subsector peers in Healthcare Equipment & Providers (median of 22.00). false

Medium
At a revenue of IDR 1.61 trillion, SAME.JK ranks 10 in Revenue out of 10 companies in the Healthcare sector.

Medium
At a profit of IDR 0.01 trillion, SAME.JK ranks 9 in Profit out of 10 companies in the Healthcare sector.

Future

Future Growth of SAME

Growth Forecasts

Analyst Ratings

No analyst ratings available yet.

Sector Benchmark

Healthcare Equipment & Providers companies in Indonesia are growing at a projected rate of 26.21% against the IDX average of +13.8%.

Healthcare Equipment & Providers sector overview

SAME Earnings & Revenue Forecast

No earnings forecast is available for SAME at the moment.

All values in IDR billion

Future growth prospect of SAME
WeightNotesScore
High
SAME's projected growth rate of 26.21% is above the ID market average of 13.82%.

High
The Healthcare Equipment & Providers sub-sector is projected to grow revenue by 25.38% in 2025. This number is higher than the previous year 2024's growth rate of 11.83%. This bodes well for SAME's revenue growth prospects in the next 2 years.

Medium
The Healthcare Equipment & Providers sub-sector is projected to increase earnings by 20.29% in 2025. This number is higher than the previous year 2024's EPS growth of -3.21%. This bodes well for SAME's earnings growth prospects in the next 2 years.

Medium
SAME and its peers in the Healthcare Equipment & Providers sub-sector belongs to the Healthcare sector. Companies in the Healthcare sector are projected to have a fruitful year heading into 2025. Specifically, earnings are projected to increase by 17.62% in 2025 while revenue growth is projected to increase by 20.39%. These macroeconomic trends will likely be a tailwind for SAME's earnings growth prospects in the next 2 years.

Technical

Daily Technical Ratings of SAME

Oscillators

Buy

Sell

0

Neutral

9

Buy

2

Summary

Buy

Sell

4

Neutral

10

Buy

12

Moving Averages

Buy

Sell

4

Neutral

1

Buy

10

Summary

Technical Ratings of SAME
IndicatorSummarySellNeutralBuy
SummaryBuy41012
OscillatorsBuy092
Moving AveragesBuy4110

Last Update: 2024-07-19

Loading...
Loading...

Management

Executive Management

President Director

Jusup Halimi15.2 years

Vice President Director

Juniwati Gunawan15.4 years
Meta Dewi ThedjaDirector
Drg. Nailufar, MarsDirector
KusmiatiDirector
Armen Antonius DjanDirector
NamePositionShares%Stock Value
(in Billion IDR)
Armen Antonius DjanDirector800,000< 0.010.20B
Drg. Nailufar, MarsDirector700,000< 0.010.18B
Juniwati GunawanVice President Director800,000< 0.010.20B
Jusup HalimiPresident Director1,855,000< 0.010.47B
KusmiatiDirector700,000< 0.010.18B
Meta Dewi ThedjaDirector700,000< 0.010.18B

Ownership

SAME Ownership

NameNumber of SharesOwnership (%)Value
Pt Elang Mahkota Teknologi Tbk13,425,388,04578.33,436.90B
Public3,716,189,50021.7951.34B

Largest Institutional Buy

No data is available for SAME at the moment.

Largest Institutional Sell

Dimensional Fund Advisors LP
Sold 31-12-2023
-759,603 shares

Institutional Transactions

Tracking institutional transactions buying / selling of SAME stock

SAME Filings

No noteworthy filings to report on

    Sectors, Indonesia's Financial Data Layer

    We hate spam as much as you do. We do not resell your data.

    Email us at sectors@supertype.ai for enquiries on using Sectors for your organization.

    © 2024 Supertype Pte. Ltd.
    (and subsidiary PT. Supertype Teknologi Nusantara)